Cerenome CNSY
NASDAQ CNSY
$2.96 +0.02 (+0.68%)
As of: Sep 3, 2026 · 3:56 PM EDT

Cerenome (CNSY) Consolidated Net Income (2011 - 2026)

Analysis

Cerenome (CNSY) Consolidated Net Income (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn 600.00 Mn
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.41 Bn 44.41 Bn - -644.37 Mn
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - 81.49 Mn
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn -13.27 Mn
10 Cerenome 20.42 Mn 11.83 Mn - -9.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -9.01 Mn
Mar 31, 2026 -6.95 Mn
Dec 31, 2025 -5.71 Mn
Sep 30, 2025 -4.42 Mn
Jun 30, 2025 -1.51 Mn
Mar 31, 2025 -4.08 Mn
Dec 31, 2024 -3.90 Mn
Sep 30, 2024 -3.78 Mn
Jun 30, 2024 -3.66 Mn
Mar 31, 2024 -3.26 Mn
Dec 31, 2023 -3.81 Mn
Sep 30, 2023 -3.22 Mn
Jun 30, 2023 -1.48 Mn
Mar 31, 2023 -4.81 Mn
Dec 31, 2022 -5.61 Mn
Sep 30, 2022 -5.25 Mn
Jun 30, 2022 -5.30 Mn
Mar 31, 2022 -4.12 Mn
Dec 31, 2021 -4.16 Mn
Sep 30, 2021 -3.73 Mn